Emerging Research in the Field of Probiotics with Jakob Axelsson & Sara Appelgren
Tues, 4th June, 8pm NZDT / 6pm AEDT
Over the last two decades, there has been a significant transformation in our comprehension of the microbiome's role in human host physiology.
Ground-breaking studies have revealed that prokaryotic residents, in comparison to human cells and genes, make an equivalent contribution in terms of cell numbers and a considerably higher contribution in terms of genes to the human “holobiont.” This microbial influence extends across various mammalian processes, encompassing digestion, metabolism, immunity, and even brain functions.[i]
This research continues to evolve rapidly, and in this webinar, Sara & Jakob will discuss the exciting results emerging from an ongoing study looking at the impact of L. reuteri probiotic strains on irritable bowel syndrome (IBS). They’ll share:
What pathophysiological mechanisms underlie IBD & IBS
Which probiotic strains have demonstrated ability to alleviate drivers and symptoms of IBD & IBS
How to incorporate probiotics in clinical protocols to alleviate common gastrointestinal conditions
Speaker: Jakob Axelsson & Sara Appelgren
Who it's for
Professional healthcare practitioners.
When & where
Tues, 4th June, 8pm NZDT / 6pm AEDT